{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Ainos, Inc."},"Symbol":{"label":"Symbol","value":"AIMD"},"Address":{"label":"Address","value":"8880 RIO SAN DIEGO DRIVE,SUITE 800, SAN DIEGO, California, 92108, United States"},"Phone":{"label":"Phone","value":"+1 858 869-2986"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Ainos is a diversified healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine. The company's products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform."},"CompanyUrl":{"label":"Company Url","value":"https://www.ainos.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Chun Hsien Tsai","title":"Chairman, President & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}